3 news items
QDEL INVESTOR ALERT: Securities Fraud Class Action Filed After QuidelOrtho (QDEL) Reports Disastrous Q4 2023 Results, Terminates CEO, Withdraws FDA Submission - Hagens Berman
QDEL
22 Apr 24
investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and fraud
QuidelOrtho (QDEL) Securities Fraud Class Action Filed After QDEL Reports Disastrous Q4 2023 Results, Terminates CEO, Withdraws FDA Submission - Hagens Berman
QDEL
17 Apr 24
is home to a robust securities litigation practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving
QuidelOrtho (QDEL) Securities Fraud Class Action Filed After QDEL Reports Disastrous Q4 2023 Results, Terminates CEO, Withdraws FDA Submission - Hagens Berman
QDEL
13 Apr 24
is home to a robust securities litigation practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving
- Prev
- 1
- Next